| This paper tests the main hypothesis of whether the Sarbanes-Oxley (SOX) act has had an adverse impact on firm's willingness to cross-list on the U.S. stock exchanges. Using univariate, OLS, panel, and treatment methods, we find evidence that although a premium still exists with cross-listing on the U.S. exchanges, SOX has had an adverse effect on firm's willingness to cross-list and that SOX has also had a contagion effect on other global stock exchanges as well. |
